This announcement is a separate document:
中外製薬：2024年12月期第2四半期（中間期）連結決算〔IFRS〕補足資料
Chugai Pharmaceutical: Supplementary information for the consolidated financial statements (IFRS) for the second quarter (interim) of the period ending in December 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.